Patents Assigned to STEPSTONE DIAGNOSTICS SARL
  • Publication number: 20180259532
    Abstract: The present invention relates to a reliable method of prediction of lower respiratory tract infection or inflammation in humans, wherein the level of pancreatic stone protein/regenerating protein (PSP/reg) is determined in serum, and a high level is indicative of the development and the severity of the disease, allowing the classification of patients according to risk.
    Type: Application
    Filed: March 5, 2018
    Publication date: September 13, 2018
    Applicants: UNIVERSITY HOSPITAL OF BASEL, STEPSTONE DIAGNOSTICS SARL
    Inventors: Daiana Stolz, Frederic Lajaunias